logo
Twitter
Discord
Email
logo
logo
Pulse Biosciences, Inc.NASDAQ - PLSE
Reports
Search reports
Name
Reporting Date
Filing Date
2024-09-30 10-Q2024-09-302024-10-30
2024-06-30 10-Q2024-06-302024-08-19
2024-03-31 10-Q2024-03-312024-05-07
2023-12-31 10-K2023-12-312024-03-28
2023-09-30 10-Q2023-09-302023-11-13
2023-06-30 10-Q2023-06-302023-08-10
2023-03-31 10-Q2023-03-312023-05-11
2022-12-31 10-K2022-12-312023-03-31
2022-09-30 10-Q2022-09-302022-11-10
2022-06-30 10-Q2022-06-302022-08-10
2022-03-31 10-Q2022-03-312022-05-11
2021-12-31 10-K2021-12-312022-03-31
2021-09-30 10-Q2021-09-302021-11-15
2021-06-30 10-Q2021-06-302021-08-09
2021-03-31 10-Q2021-03-312021-05-10
2020-12-31 10-K2020-12-312021-03-12
2020-09-30 10-Q2020-09-302020-11-09
2020-06-30 10-Q2020-06-302020-08-10
2020-03-31 10-Q2020-03-312020-05-11
2019-12-31 10-K2019-12-312020-03-31
1
2
20 / page
About
Name
Pulse Biosciences, Inc.
Overview
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Show More
CEO
Mr. Robert W. Duggan
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Listing Date
2016-05-18
Address
3957 Point Eden Way, Hayward, CA, 94545, United States
Tel
510-906-4600
Website
https://www.pulsebiosciences.com